ArticlePharmaceutics2021

Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization.

Mohammad A M Momin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.